AlphaStocks
3.9
Weak

ARTIVION, INC. (AORT)

Health Care / Health Care Equipment

S&P SmallCap 600

$34.14

Scores poorly across most models. Proceed with caution.

Weak

Score based on 4 of 5 models — moderate confidence

#860out of 1127 in Health Care

Is ARTIVION, INC. a Good Investment in 2026?

ARTIVION, INC. (AORT) scores 3.9 out of 10 on AlphaStocks' composite model, earning a Weak rating. The Piotroski model rates ARTIVION, INC. as Strong (7/9). However, the Greenblatt Magic Formula model rates it Caution — Bottom half (rank 71%). ARTIVION, INC. currently trades above its estimated fair value of $16, suggesting limited upside at current prices. ARTIVION, INC. ranks #860 out of 1127 stocks in the Health Care sector.

This summary is algorithmically generated and is not financial advice.

Key Metrics

P/E164.8ROE1.9Market Cap2B

Estimated Fair Value

$15.65118% above

Trading above estimated fair value. P/e of 165x implies high growth expectations.

Model-based estimate, not a price target.

5-Model Analysis

Each model evaluates this stock from a different angle. Combined, they form the composite score above.

Piotroski

Strong

7/9

Buffett

Neutral

Business quality & competitive moat

Graham

Caution

Significantly above fair value

Lynch

Neutral

Growth rate vs price (PEG)

Greenblatt

Caution

Bottom half (rank 71%)

Frequently Asked Questions

Is ARTIVION, INC. (AORT) a good investment?
Based on AlphaStocks' composite analysis, ARTIVION, INC. (AORT) scores 3.9 out of 10, earning a Weak rating. This score is below average, suggesting caution. Trading above estimated fair value. P/e of 165x implies high growth expectations.
What is ARTIVION, INC.'s Piotroski F-Score?
ARTIVION, INC.'s Piotroski F-Score status is Strong. The raw score is 7/9. The Piotroski F-Score evaluates financial health using 9 fundamental signals including profitability, leverage, and operating efficiency.
Is AORT overvalued or undervalued?
Based on AlphaStocks' model-based fair value estimate of $16, AORT appears overvalued. The stock currently trades 118% above its estimated fair value. Trading above estimated fair value. P/e of 165x implies high growth expectations.
How does AORT compare to other Health Care stocks?
ARTIVION, INC. ranks #860 out of 1127 stocks in the Health Care sector, placing it in the top 76% of its sector by composite score. There are higher-ranked alternatives in this sector worth exploring.
What do investment models say about AORT?
AlphaStocks evaluates AORT using five proven investment models. Piotroski: Strong; Buffett: Neutral; Graham: Caution; Lynch: Neutral; Greenblatt Magic Formula: Caution. These models are combined into a single composite score of 3.9/10.

Similar Stocks

PARRFTIAZN

Compare AORT with

AORT vs PARRAORT vs FTIAORT vs AZN

Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer